Skip to main content
. 2014 Apr 21;20(15):4230–4243. doi: 10.3748/wjg.v20.i15.4230

Table 1.

Frequency of CpG island methylator phenotype-high in colorectal cancers: A review of the literature

Ref. Country CIMP-H CRCs/tested CRCs n (%)
In all CRCs In MSI-H CRCs
Western countries
Samowitz et al[22], 2005 United States 250/859 (29.1) 64/78 (82.1)
Weisenberger et al[13], 2006 United States 33/187 (17.6) NA
Samowitz et al[84], 2006 United States 313/1271 (24.6) 105/170 (61.8)
Barault et al[85], 2008 France 95/578 (16.4) 58/80 (72.5)
Ogino et al[4], 2009 United States 123/631 (19.5) 86/118 (72.9)
Dahlin et al[86], 2010 Sweden 46/411 (11.2) 34/61 (55.7)
Zlobec et al[24], 2011 Switzerland 22/314 (7) NA
Lochhead et al[63], 2013 United States 205/1173 (17.5) 140/184 (76.1)
Eastern countries
Koinuma et al[101], 2004 Japan NA 161/28 (57.1)
Nagasaka et al[102], 2008 Japan and Germany NA 152/36 (41.7)
Kim et al[98], 2009 South Korea 29/271 (10.7) 8/33 (24.2)
Min et al[99], 2011 South Korea 34/245 (13.9) NA
Bae et al[97], 2013 South Korea 47/734 (6.4) 18/65 (27.7)
Kim et al[25], 2013 South Korea NA 64/220 (29.1)
1

MLH1-methylated colorectal cancers (CRCs) instead of CpG island methylator phenotype-high (CIMP-H) CRCs;

2

Sporadic microsatellite instability-high (MSI-H) CRCs instead of CIMP-H CRCs. NA: Not applicable.